Evidence map›Paper›PMID 40573386›Full record

ReviewViruses2025

The Role of Chemical Modifications in the Genome of Negative-Sense RNA Viruses on the Innate Immune Response.

María-Alejandra Ceballos, Mónica L Acevedo

Abstract readReview
In one paragraph

Review in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

María-Alejandra CeballosLaboratory of Molecular and Cellular Virology, Virology Program, Faculty of Medicine, Institute of Biomedical Sciences, Universidad de Chile, Santiago 8330015, Chile.
Mónica L AcevedoLaboratory of Molecular and Cellular Virology, Virology Program, Faculty of Medicine, Institute of Biomedical Sciences, Universidad de Chile, Santiago 8330015, Chile.ORCID 0000-0002-2289-6667

Funding

Fondecyt 1231275
6 · The paper itself

Abstract

Negative-sense RNA viruses comprise a wide array of viral families, such as Orthomyxoviridae, Paramyxoviridae, Rhabdoviridae, and Morbillivirus, all of which are adept at inciting significant epidemic outbreaks. Throughout their replication cycle, these viruses engage in a variety of RNA modifications, during both the co-transcriptional and post-transcriptional phases, which are mediated by specific enzymatic activities. These chemical alterations play a critical role in shaping viral fitness, particularly in terms of evading innate immune responses. Key chemical modifications, such as adenosine methylation, 2'-O methylation of nucleosides, and adenosine-to-inosine editing, play critical roles in determining the stability, translational efficiency, and immune recognition of viral RNA. These modifications can reduce the activation of immune sensors, thereby suppressing interferon production and broader antiviral responses. In contrast, certain modifications may enhance immune recognition, which opens avenues for novel vaccine and antiviral strategy development. A comprehensive understanding of these RNA chemical modifications and their implications for virus-host interactions is essential for advancing therapeutic strategies aimed at manipulating innate immunity and optimizing the efficacy of RNA-based vaccines. This review examines the mechanisms and implications of RNA chemical modifications in negative-sense RNA viruses, emphasizing their dual roles in either evading or activating the innate immune system.

Indexed as

Genome, ViralImmunity, InnateNegative-Sense RNA VirusesRNA, ViralAdenosineAnimalsHost-Pathogen InteractionsHumansMethylationRNA Processing, Post-TranscriptionalRNA Virus InfectionsVirus ReplicationAdenosineRNA, Viral2′-O-methylationepitranscriptomicinnate immunityinosineN6,2′O-dimethyladenosineN6-methyladenosineN7-methylguanosinenegative-polarity single-stranded RNA virusespseudouridineRNA chemical modifications

Identifiers

PMID40573386
PMCPMC12197367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.